Publications

Gene Expression Analysis of Paired Baseline (Bl) and On-Treatment Tumor Samples from Fairlane, a Double-Blind Placebo (Pbo)-Controlled Randomized Phase Ii Trial of Neoadjuvant Ipatasertib (Ipat) plus Paclitaxel (Pac) in Early Triple-Negative Breast Cancer (Etnbc)

AuthID
P-00R-5Y3

Author(s)

Shi, Z

Isakoff, SJ

Saura, C

Nuciforo, P

Calvo, I

Andersen, J

Passos Coelho, JLP

Gil Gil, MG

Bermejo, B

Patt, DA

Ciruelos, E

Wongchenko, MJ

Singel, SM

Xu, N

de la Pena, L

Baselga, J

Gendreau, S

Oliveira, M

Document Type

Abstract

Year published

2019

Published

in CANCER RESEARCH, ISSN: 0008-5472

Volume: 79, Issue: 13

Conference

Annual Meeting of the American-Association-For-Cancer-Research (Aacr), Date: MAR 29-APR 03, 2019, Location: Atlanta, GA, Sponsors: Amer Assoc Canc Res

Indexing

Wos^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1158/1538-7445.am2019-4891

Wos: WOS:000488279405248

Source Identifiers

ISSN: 0008-5472

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Gene Expression Analysis of Paired Baseline (Bl) and On-Treatment Tumor Samples from Fairlane, a Double-Blind Placebo (Pbo)-Controlled Randomized Phase Ii Trial of Neoadjuvant Ipatasertib (Ipat) plus Paclitaxel (Pac) in Early Triple-Negative Breast Cancer (Etnbc)

Useful Links

Get Help

Federated Authentication (Click on the image)

Gene Expression Analysis of Paired Baseline (Bl) and On-Treatment Tumor Samples from Fairlane, a Double-Blind Placebo (Pbo)-Controlled Randomized Phase Ii Trial of Neoadjuvant Ipatasertib (Ipat) plus Paclitaxel (Pac) in Early Triple-Negative Breast Cancer (Etnbc)

Useful Links

Get Help